Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Expert Guidance from the ACR/ARP Access in Rheumatology Meeting

Glen Rodman  |  June 20, 2023

ACR/ARP Access in Rheumatology—As part of ACR Education Exchange 2023, the ACR/ARP Access in Rheumatology meeting addressed some of the major challenges in coverage and payment that U.S. rheumatology practices face.

Speakers included rheumatologists, rheumatology professionals, office managers and CEOs. The first section, Thriving, Not Just Surviving—Keeping Your Rheumatology Practice Solvent, focused on financial management for rheumatology clinics. In the second section, Optimizing Patient Access to Treatment, speakers discussed obstacles to care related to biosimilars, Medicare and prior authorization.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Keep Your Practice Solvent

Mr. Haberkern

The first speaker, Charles Haberkern, MBA, is an entrepreneurial healthcare executive and the CEO of Arthritis, Rheumatic & Bone Disease Associates. In his presentation, Cash Flow Considerations, Mr. Haberkern shared tips from his 25 years of financial experience, advising, “You have to take care of patients first, but if you’re losing money, you can’t take care of patients.”

Mr. Haberkern advised his audience to set aside money to pay invoices when they come due—rather than right away—so the funds can accrue interest while in the bank.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Nehad Soloman, MD, FACR, is a Phoenix-based rheumatologist, a recipient of multiple awards for research and academic excellence and a public speaker for the Arthritis Foundation. In his presentation, Dr. Soloman brought the perspective of both administrator and physician to his analysis of the buy-and-bill model used by infusion centers. Under the buy-and-bill model, healthcare providers purchase certain medicines that require special handling and storage and store them at their practices until they are needed by a patient. Medicare then reimburses physicians for these therapies.

Dr. Soloman

Dr. Soloman emphasized the utility of observing metrics to understand the roles of every person on a team and ensure each person is responsible for their own role. He underscored the importance of resource and inventory management in infusion clinics and advised practices to keep track of drugs by doctor and by quarter to ensure resources are distributed without disparities.

Christopher Phillips, MD, the final speaker of the first session, is a rheumatologist affiliated with Mercy Health-Lourdes Hospital, Paducah, Ky. He delivered a presentation on how to operate a successful infusion clinic. He cautioned against making “bad assumptions”—for example, assuming that a practice’s infusion nurse will never leave that practice. “If you only have one person you rely upon, that person is … more of a key employee than you are to your practice’s survival,” so make sure your pay is competitive and your employees’ needs are met, Dr. Phillips advised.

Page: 1 2 3 | Single Page
Share: 

Filed under:Meeting ReportsPractice Support Tagged with:Access in Rheumatologyfinancial planninghealthcare access

Related Articles
    Georgia Bonney

    Prior Authorization Woes: Barriers to & Delays in Care, Administrative Hassles & Potential Solutions

    August 6, 2021

    As insurers phase out pandemic-related flexibilities, many are raising new obstacles to try to limit their financial exposure.

    Marching to the Biosimilar Beat: Questions on Rollout Remain

    September 7, 2023

    The availability of biosimilars for the treatment of patients with rheumatic diseases exploded in 2023. Here’s where we stand and what to expect going forward.

    Dr. Chris Phillips Competes in Triathlons

    October 18, 2018

    “I think I’m mentally sharper when I have been exercising and taking care of myself,” says Chris Phillips, MD, a rheumatologist in solo practice in Paducah, Ky. Dr. Phillips has recognized these benefits since high school, when he began participating in competitive sports. Four years ago, Dr. Phillips was competing against 40 other cyclists in…

    Report on EU’s Experience with Biosimilar Drugs Released: Will U.S. Experience Be Similar?

    October 17, 2017

    As questions about biosimilar medications swirl among U.S. rheumatologists, a recently released report sheds some light on the European experience with biosimilars—and may offer some important insights for the U.S. market. The report, Biosimilars in the EU: Information Guide for Healthcare Professionals, was released in late April by the European Medicines Agency (EMA) and the…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences